Efficacy of IgE in Mediating Allergic Reactions in Vivo
Efficacy of IgE in Mediating Allergic Reactions in Vivo
批准号:
7263974
负责人:
Donald W MacGlashan
金额:
$111.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2011-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The central element in allergic diseases such as asthma, rhinitis and eczema, is the presence of IgE antibody. While there is general acceptance of the central role for IgE in these diseases, there remains only a poor understanding of the quantitative requirements for IgE in the expression of these diseases. This application focuses on obtaining better quantitative insights on several aspects of the problem. In project by Bochner, two underlying hypotheses are examined, 1) that it is the ratio of antigen-specific IgE to total IgE that is a critical determinant of an in vivo response to allergen challenge and 2) that mast cells are a central determinant in early tissue localized reactions like those in the nose while basophils are involved in food reactions where antigen exposure is likely to occur in the blood. Project 2 offers an extended hypothesis for critical parameters, that not only is the specific to total IgE ratio important, but cellular sensitivity (the quantitative assessment of a cell's ability to respond to antigen) also defines the response. Other aims in project by Macglashan address issues of FceRI expression, how the beta subunit of this receptor is controlled and its influence on overall expression of FceRI and how other early signaling molecule expression is regulated by IgE antibody. A common theme in these studies as well as a theme that binds the various projects together is that the regulation is quantitatively different in vivo than in vitro and we will be assessing these differences and how they influence our understanding of disease expression. In one respect, project by Shroeder re-examines quantitative aspects of basophil and mast cell responses. While staying with the theme of IgE centrality, Project 3 examines the FceRI-bearing antigen-presenting cells and the interaction of FceRI and innate immune receptors. Aims in this project will examine how changes in IgE antibody alter expression of FceRI on dendritic cells and whether this results in changes in the expression and profile of cytokines elaborated by these cells. Changes in the expression and function of innate receptors on dendritic cells and basophils will also be a focus of this project. Finally, this project will examine the influence of IgE on the systemic effects of large local reactions by examining various parameters of basophil and dendritic cell function following in vivo manipulation of IgE and experimental antigen exposure. All projects will modulate IgE levels in vivo to make quantitative determinations of the effects these changes have on various outcomes associated with allergic diseases. Beyond the required administrative core (A), there are two scientific Cores. The Subject Characterization and Recruitment Core provides the comprehensive subject recruitment and characterization that is required for all three projects. The Diagnostics Core provides the comprehensive diagnostic and laboratory assays needed for all three projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Syk Expression in Human Basophils
-
批准号:10434940
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2021
-
负责人:Donald W MacGlashan
-
依托单位:
Regulation of Syk Expression in Human Basophils
-
批准号:10633098
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2021
-
负责人:Donald W MacGlashan
-
依托单位:
Regulation of Syk Expression in Human Basophils
-
批准号:10276240
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2021
-
负责人:Donald W MacGlashan
-
依托单位:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
-
批准号:8628227
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2014
-
负责人:Donald W MacGlashan
-
依托单位:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
-
批准号:8810641
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2014
-
负责人:Donald W MacGlashan
-
依托单位:
Human Basophil Phenotypes and Therapeutic Outcomes
-
批准号:8707080
-
项目类别:
-
资助金额:$44.47万
-
财政年份:2013
-
负责人:Donald W MacGlashan
-
依托单位:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
-
批准号:8482055
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2012
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7914972
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2009
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7134190
-
项目类别:
-
资助金额:$111.7万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
FcERI Expression, Cellular Sensitivity, In vivo Response
-
批准号:7150225
-
项目类别:
-
资助金额:$24.62万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Administration
-
批准号:7150230
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7487023
-
项目类别:
-
资助金额:$113.08万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7666139
-
项目类别:
-
资助金额:$116.43万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
-
批准号:7901048
-
项目类别:
-
资助金额:$118.68万
-
财政年份:2006
-
负责人:Donald W MacGlashan
-
依托单位:
REGULATION OF FCERI EXPRESSION
-
批准号:6149865
-
项目类别:
-
资助金额:$22.0万
-
财政年份:1998
-
负责人:Donald W MacGlashan
-
依托单位:
REGULATION OF FCERI EXPRESSION
-
批准号:2451108
-
项目类别:
-
资助金额:$20.77万
-
财政年份:1998
-
负责人:Donald W MacGlashan
-
依托单位:
REGULATION OF FCERI EXPRESSION
-
批准号:2871563
-
项目类别:
-
资助金额:$21.26万
-
财政年份:1998
-
负责人:Donald W MacGlashan
-
依托单位:
MECHANISMS OF HUMAN BASOPHIL & MAST CELL DESENSITIZATION
-
批准号:3129810
-
项目类别:
-
资助金额:$14.99万
-
财政年份:1984
-
负责人:Donald W MacGlashan
-
依托单位:
MECHANISMS OF HUMAN BASOPHIL & MAST CELL DESENSITIZATION
-
批准号:3129817
-
项目类别:
-
资助金额:$15.54万
-
财政年份:1984
-
负责人:Donald W MacGlashan
-
依托单位:
MECHANISMS OF HUMAN BASOPHIL & MAST CELL DESENSITIZATION
-
批准号:3129814
-
项目类别:
-
资助金额:$13.18万
-
财政年份:1984
-
负责人:Donald W MacGlashan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
乌梅三豆饮治疗慢性荨麻疹的疗效观察及对血清 IgE的影响
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:重庆市江北区中医院
-
依托单位:
补肺健脾合剂经调节肠道菌群抑制IgE超敏反应治疗儿童食物过敏的新机制
-
批准号:2025JJ80924
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蒋屏
-
依托单位:
Neuritin调控嗜酸粒细胞性鼻息肉IgE产生及机制的研究
-
批准号:JCZRJQ202500045
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Th9细胞通过STAT6依赖性信号通路对记忆过敏性哮喘小鼠IgE轴的调控机制研究
-
批准号:JCZRYB202500900
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
变应性鼻炎中IL-35通过对滤泡调节性T细胞的调控抑制变应原特异性IgE的生成及其相关机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:刘文龙
-
依托单位:
IL-25/DC/OX40L轴通过调控Tfh2细胞分化诱导嗜酸性鼻息肉局部IgE产生的作用和机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:孙悦奇
-
依托单位:
CHD1L敲除促进B细胞IgE抗体类别转换的分子机制及其抗肿瘤作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:曾军
-
依托单位:
SPINK5基因缺陷致Netherton综合征血清IgE抗体升高的类别转换机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:白晓明
-
依托单位:
粉尘螨代谢物Hepoxilin A3促进IgE类别转换的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:吉坤美
-
依托单位:
树突状细胞通过极化Tfh2细胞参与嗜酸性鼻息肉局部IgE产生的调控机制研究
-
批准号:82371114
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:孙悦奇
-
依托单位: